Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST studyGerrit M. Große, Anika Hüsing, Andreas Stang et al.|International Journal of Stroke|2023Cited by 16
Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation RegistryKarl Georg Hæusler, Matthias Endres, Serdar Tütüncü et al.|EP Europace|2019Cited by 12
Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation RegistrySerdar Tütüncü, Karl Georg Hæusler, Manuel C. Olma et al.|Journal of Neurology|2021Cited by 12
Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation RegistryManuel C. Olma, Karl Georg Hæusler, Serdar Tütüncü et al.|Open Heart|2024Cited by 7
Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trialKatrin Wasser, Johann Pelz, Andrea Kraft et al.|Neurological Research and Practice|2025Cited by 3